Despite having been one of the countries leading in the global campaign to eliminate viral hepatitis, Australia may now not meet its 2022 national hepatitis C treatment target or the 2030 global target.

The proportion of people with hepatitis C taking up treatment has dropped steadily since the initial surge in 2016. Although close to half of Australians living with hepatitis C have been treated since, we will not meet our national target of having 65% treated by 2022 if the decline continues. Nor will we meet the 2030 global target of treating 80% of people with hepatitis C.